Literature DB >> 19082594

Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors.

Songul Serefhanoglu1, Hakan Goker, Yahya Buyukasik, Mehmet Turgut, Nilgun Sayinalp, Ibrahim Celalettin Haznedaroglu, Salih Aksu, Umit Akman, Osman Ilhami Ozcebe.   

Abstract

The roles of vascular endothelial growth factor (VEGF), Tie-2, and angiopoietins in the mobilization of the hematopoietic stem cells (HSCs) in humans are not yet clearly understood. In order to elucidate mechanisms of HSC mobilization from their niches, we aimed to investigate the effects of mobilization with granulocyte colony-stimulating factor to the levels of VEGF, Tie-2, and angiopoietins 1 and 2 in the allogeneic HSC transplantation donors. Soluble VEGF, Tie-2, angiopoietin 1 and angiopoietin 2 levels were studied in 20 healthy allogeneic HSC transplantation donors before (from peripheral blood) and 5 days after mobilization (from apheresis material). Mean VEGF level in the postmobilization apheresis sample was significantly higher compared to baseline premobilization peripheral blood (t test, p < 0.001). In contrast, mean Tie-2 level in the postmobilization aphaeresis sample was significantly lower compared to baseline premobilization peripheral blood (t test, p = 0.01). Angiopoietin 1 and angiopoietin 2 levels did not differ between baseline and postmobilization samples. A significant rise in VEGF level after mobilization suggests stimulation of the angiogenesis. A significant fall in Tie-2 level suggests suppression of the angiopoietin 1/Tie-2 signaling, leading to release of HSC from the hematopoietic niches and mobilization to the peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082594     DOI: 10.1007/s00277-008-0657-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  4 in total

1.  Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies.

Authors:  Anna Szmigielska-Kaplon; Anna Krawczynska; Magdalena Czemerska; Agnieszka Pluta; Barbara Cebula-Obrzut; Katarzyna Szmigielska; Konrad Stępka; Piotr Smolewski; Tadeusz Robak; Agnieszka Wierzbowska
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

2.  Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.

Authors:  Fabio Di Giacomo; Daniel Lewandowski; Eric Cabannes; Vanessa Nancy-Portebois; Maurice Petitou; Serge Fichelson; Paul-Henri Romeo
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

3.  Evaluation of mobilized peripheral blood CD34(+) cells from patients with severe coronary artery disease as a source of endothelial progenitor cells.

Authors:  Abba C Zubair; Sunita Malik; Athena Paulsen; Masakazu Ishikawa; Christopher McCoy; Peter X Adams; David Amrani; Marco Costa
Journal:  Cytotherapy       Date:  2010-04       Impact factor: 5.414

4.  Treatment of Cerebral Palsy with Stem Cells: A Report of 17 Cases.

Authors:  Nassim H Abi Chahine; Tarek W Wehbe; Ramzi A Hilal; Victoria V Zoghbi; Alia E Melki; Emil B Bou Habib
Journal:  Int J Stem Cells       Date:  2016-05-30       Impact factor: 2.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.